Patent · US Active

Bruton'S tyrosine kinase inhibitors

US9249146B2 · kind B2 · utility

5Cited by
12References
25Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 26, 2014
Grant dateFeb 2, 2016
Priority date
Expiry dateJun 26, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/519
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds useful as inhibitors of Btk, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.